Spyre Therapeutics, Inc (SYRE): 424B5 filed Oct 6, 2026

Form type

424B5

Filing date

Oct 6, 2026

Accession number

0001628280-26-065249

Filer

Spyre Therapeutics, Inc (CIK 1636282)